It is a chemicals and materials private limited company based in Hubli, Karnataka, India, established in 2022.
2022 | Hubli, Karnataka, India | ActiveSpecsyn Laboratories Private Limited, a active private limited company, was established on 25 July 2022 in Hubli, Karnataka, India. Engaging in industrial chemicals within the chemicals and materials sector, it holds CIN: U24290KA2022PTC164257. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹2.50 Cr.
It upholds a compliant status. Its leadership includes Rajesh Balakrishna Bhat (Additional Director), Rekha Vivek Nayak (Director), Reshma Ganapati Shankarling (Director). Past directors included Rajesh Bhat Roopa, Rekha Vivek Nayak, Kamaldeep Raghuveer Nayak. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 131/1A, Anchatageri Village, Karwar Road,, Hubli, Karnataka, 580024.
U24290KA2022PTC164257
164257
25 July 2022
₹4.00 Cr
₹2.50 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Specsyn Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Balakrishna Bhat | Additional Director | 11 Aug 2025 | Current |
| Rekha Vivek Nayak | Director | 25 Jul 2022 | Current |
| Reshma Ganapati Shankarling | Director | 25 Jul 2022 | Current |
| Kamaldeep Raghuveer Nayak | Director | 25 Jul 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Jul 2024 | Past |
| Pramod Abcsdd | Nominee Director | 25 Jul 2022 | Past |
| Pramod Abcsdd | Nominee Director | 25 Jul 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Specsyn Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Specsyn Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Specsyn Laboratories has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Specsyn Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Specsyn Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rajesh Balakrishna Bhat was appointed as a Additional Director was appointed as a Additional Director on 11 Aug 2025 & has been associated with this company since 3 months 22 days . was completed.
Specsyn Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Specsyn Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Progress on Rekha Vivek Nayak was appointed as a Director was appointed as a Director on 25 Jul 2022 & has been associated with this company since 3 years 4 months . was documented.
Reshma Ganapati Shankarling was appointed as a Director was appointed as a Director on 25 Jul 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.
Progress on Kamaldeep Raghuveer Nayak was appointed as a Director was appointed as a Director on 25 Jul 2022 & has been associated with this company since 3 years 4 months . was documented.
The CIN of Specsyn Laboratories Private Limited is U24290KA2022PTC164257.
Specsyn Laboratories Private Limited is headquartered at No. 131/1A, Anchatageri Village, Karwar Road,, Hubli, Karnataka, 580024.
Specsyn Laboratories Private Limited was incorporated on 25 July 2022.
The current directors of Specsyn Laboratories Private Limited are
The primary industry of Specsyn Laboratories Private Limited is Chemicals And Materials.
Specsyn Laboratories Private Limited is unlisted.
The authorized capital of Specsyn Laboratories Private Limited is ₹4.00 Cr, and the paid-up capital is ₹2.50 Cr.
The compliance status of Specsyn Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX